Chloromycetin
 Chloromycetin ophthalmic ointment

drug-information.ru

|Chloromycetin Chloromycetin ophthalmic ointment

Drugs search, click the first letter of a drug name:


| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 9  Home

Chloromycetin


Generic Name: chloramphenicol sodium succinate
Dosage Form: Injection

FOR INTRAVENOUS ADMINISTRATION

WARNING

Serious and fatal blood dyscrasias (aplastic anemia, hypoplastic anemia, thrombocytopenia, and granulocytopenia) are known to occur after the administration of chloramphenicol. In addition, there have been reports of aplastic anemia attributed to chloramphenicol which later terminated in leukemia. Blood dyscrasias have occurred after both short-term and prolonged therapy with this drug.Chloramphenicol must not be used when less potentially dangerous agents will be effective, as described in the INDICATIONS AND USAGE section.It must not be used in the treatment of trivial infections or where it is not indicated, as in colds, influenza, infections of the throat; or as a prophylactic agent to prevent bacterial infections.

Precautions: It is essential that adequate blood studies be made during treatment with the drug. While blood studies may detect early peripheral blood changes, such as leukopenia, reticulocytopenia, or granulocytopenia, before they become irreversible, such studies cannot be relied on to detect bone marrow depression prior to development of aplastic anemia. To facilitate appropriate studies and observation during therapy, it is desirable that patients be hospitalized.

IMPORTANT CONSIDERATIONS IN PRESCRIBING INJECTABLE CHLORAMPHENICOL SODIUM SUCCINATE

CHLORAMPHENICOL SODIUM SUCCINATE IS INTENDED FOR INTRAVENOUS USE ONLY. IT HAS BEEN DEMONSTRATED TO BE INEFFECTIVE WHEN GIVEN INTRAMUSCULARLY.

  1. Chloramphenicol sodium succinate must be hydrolyzed to its microbiologically active form, and there is a lag in achieving adequate blood levels compared with the base given intravenously.

  2. Patients started on intravenous chloramphenicol sodium succinate should be changed to the oral form of another appropriate antibiotic as soon as practicable.

Description

Chloramphenicol is an antibiotic that is clinically useful for, and should be reserved for, serious infections caused by organisms susceptible to its antimicrobial effects when less potentially hazardous therapeutic agents are ineffective or contraindicated. Sensitivity testing is essential to determine its indicated use, but may be performed concurrently with therapy initiated on clinical impression that one of the indicated conditions exists (see INDICATIONS AND USAGE section).

When reconstituted as directed, each vial contains a sterile solution equivalent to 100 mg of chloramphenicol per mL (1g/10mL).

Each gram (10 mL of a 10% solution) of chloramphenicol sodium succinate contains approximately 52 mg (2.25 mEq) of sodium.

The chemical name for chloramphenicol sodium succinate is D-threo-(—)-2, 2-Dichloro-N-[ß-hydroxy-d-(hydroxymethyl)-p-nitrophenethyl] acetamide α-(sodium succinate)

The empirical and structural formulas are:

Clinical Pharmacology

Chloramphenicol administered orally is absorbed rapidly from the intestinal tract. In controlled studies in adult volunteers using the recommended dosage of 50 mg/kg/day, a dosage of 1 g every 6 hours for 8 doses was given. Using the microbiological assay method, the average peak serum level was 11.2 mcg/mL one hour after the first dose. A cumulative effect gave a peak rise to 18.4 mcg/mL after the fifth dose of 1 g. Mean serum levels ranged from 8 to 14 mcg/mL over the 48-hour period. Total urinary excretion of chloramphenicol in these studies ranged from a low of 68% to a high of 99% over a three-day period. From 8% to 12% of the antibiotic excreted is in the form of free chloramphenicol; the remainder consists of microbiologically inactive metabolites, principally the conjugate with glucuronic acid. Since the glucuronide is excreted rapidly, most chloramphenicol detected in the blood is in the microbiologically active free form. Despite the small proportion of unchanged drug excreted in the urine, the concentration of free chloramphenicol is relatively high, amounting to several hundred mcg/mL in patients receiving divided doses of 50 mg/kg/day. Small amounts of active drug are found in bile and feces. Chloramphenicol diffuses rapidly, but its distribution is not uniform. Highest concentrations are found in liver and kidney, and lowest concentrations are found in brain and cerebrospinal fluid. Chloramphenicol enters cerebrospinal fluid even in the absence of meningeal inflammation, appearing in concentrations about half of those found in the blood. Measurable levels are also detected in pleural and in ascitic fluids, saliva, milk, and in the aqueous and vitreous humors. Transport across the placental barrier occurs with somewhat lower concentration in cord blood of neonates than in maternal blood.

Microbiology

Chloramphenicol is a broad-spectrum antibiotic originally isolated from Streptomyces venezuelae. It inhibits bacterial protein synthesis by interfering with the transfer of activated amino acids from soluble RNA to ribsomes. In vitro, chloramphenicol exerts mainly a bacteriostatic effect on a wide range of gram-negative and gram-positive bacteria. Bacteriological studies should be performed to determine the causative organisms and their susceptibilities to chloramphenicol.

Chloramphenicol has been shown to be active against most strains of the following microorganisms, both in vitro and in clinical infections as described in the INDICATIONS AND USAGE section.

Aerobic gram-negative microorganisms

Haemophilus influenzae

Salmonella species, including Salmonella typhi

Other microorganisms

Lymphogranuloma-psittacosis group

Rickettsia

Susceptibility Testing Methods

Dilution Techniques: Quantitative methods are used to determine antimicrobial minimum inhibitory concentrations (MICs). These MICs provide estimates of the susceptibility of bacteria to antimicrobial compounds. The MICs should be determined using a standardized procedure. Standardized procedures are based on a dilution method1,3 (broth or agar) or equivalent with standardized inoculum concentrations and standardized concentrations of chloramphenicol powder. The MIC values should be interpreted according to the following criteria:

For testing extraintestinal isolates of Salmonella species:
MIC (µg/mL) Interpretation
< 8 Susceptible (S)
16 Intermediate (I)
> 32 Resistant (R)
For testing Haemophilus influenzaea:
MIC (µg/mL) Interpretation
< 2 Susceptible (S)
4 Intermediate (I)
> 8 Resistant (R)

aThese MIC interpretative standards are applicable only to broth microdilution susceptibility tests with Haemophilus influenzae using Haemophilus Test Medium (HTM)1.

A report of “Susceptible” indicates that the pathogen is likely to be inhibited if the antimicrobial compound in the blood reaches the concentrations usually achievable. A report of “Intermediate” indicates that the result should be considered equivocal, and, if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. This category implies possible clinical applicability in body sites where the drug is physiologically concentrated or in situations where high dosage of drug can be used. This category also provides a buffer zone which prevents small uncontrolled technical factors from causing major discrepancies in interpretation. A report of “Resistant” indicates that the pathogen is not likely to be inhibited if the antimicrobial compound in the blood reaches the concentrations usually achievable; other therapy should be selected.

Standardized susceptibility test procedures require the use of laboratory control microorganisms to control the technical aspects of the laboratory procedures. Standard chloramphenicol powder should provide the following MIC values:

Microorganism MIC (µg/mL)
Escherichia coli ATCC 25922 2-8
Haemophilus influenzaeb ATCC 49247 0.25-1

bThis MIC quality control range is applicable to only Haemophilus influenzae ATCC 49247 tested by broth microdilution procedure using Haemophilus Test Medium (HTM)1.

Diffusion Techniques: Quantitative methods that require measurement of zone diameters also provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. One such standardized procedure2,3 requires the use of standardized inoculum concentrations. This procedure uses paper disks impregnated with 30µg chloramphenicol to test the susceptibilty of microorgansims to chloramphenicol.

Reports from the laboratory providing results of the standard single-disk susceptibility test with a 30-µg chloramphenicol disk should be interpreted according to the following criteria:

For testing extraintestinal isolates of Salmonella species:
Zone Diameter (mm) Interpretation
> 18 Susceptible (S)
13-17 Intermediate (I)
< 12 Resistant (R)
For testing Haemophilus influenzaec:
Zone Diameter Interpretation
≥ 29 Susceptible (S)
26-28 Intermediate (I)
< 25 Resistant (R)

CThese zone diameter interpretative standards are applicable only to susceptibility tests performed by disk diffusion with Haemophilus influenzae using Haemophilus Test Medium (HTM)2.

As with standardized dilution techniques, diffusion methods require the use of laboratory control microorganisms to control the aspects of the laboratory procedures. For the diffusion technique, the 30µg chloramphenicol disk should prodvide the following zone diameters in these laboratory test quality control strains:

Microorgansim Zone diameter (mm)
Escherichia coli ATCC 25922 21-27
Haemophilus influenzaed ATCC 49247 31-40

dThese zone diameter quality control limits are applicable to only Haemophilus influenzae ATCC 49247 tested by a disk diffusion method using Haemophilus Test Medium (HTM)2.

Indications and Usage

In accord with the concepts in the Warning Box and this INDICATIONS AND USAGE section, chloramphenicol must be used only in those serious infections for which less potentially dangerous drugs are ineffective or contraindicated. However, chloramphenicol may be chosen to initiate antibiotic therapy on the clinical impression that one of the conditions below is believed to be present; in vitro sensitivity tests should be performed concurrently so that the drug may be discontinued as soon as possible if less potentially dangerous agents are indicated by such tests. The decision to continue use of chloramphenicol rather than another antibiotic when both are suggested by in vitro studies to be effective against a specific pathogen should be based upon severity of the infection, susceptibility of the pathogen to the various antimicrobial drugs, efficacy of the various drugs in the infection, and the important additional concepts contained in the Warning Box above.

1. Acute infections caused by Salmonella typhi*

It is not recommended for the routine treatment of the typhoid carrier state.

2. Serious infections caused by susceptible strains in accordance with the concepts expressed above:

a) Salmonella species

b) H. influenzae, specially meningeal infections

c) Rickettsia

d) Lymphogranuloma-psittacosis group

e) Various gram-negative bacteria causing bacteremia, meningitis, or other serious gram-negative infections

f) Other susceptible organisms which have been demonstrated to be resistant to all other appropriate antimicrobial agents.

3. Cystic fibrosis regimens

*In treatment of typhoid fever some authorities recommend that chloramphenicol be administered at therapeutic levels for 8 to 10 days after the patient has become afebrile to lessen the possibility of relapse.

Contraindications

Chloramphenicol is contraindicated in individuals with a history of previous hypersensitivity and/or toxic reaction to it. It must not be used in the treatment of trivial infections or where it is not indicated, as in colds, influenza, infections of the throat; or as a prophylactic agent to prevent bacterial infections.

Precautions

General

Repeated courses of chloramphenicol treatment should be avoided if at all possible. Treatment should not be continued longer that required to produce a cure with little or no risk or relapse of the disease.

Excessive blood levels may result from administration of the recommended dose to patients with impaired liver or kidney function. The dosage should be adjusted accordingly, or preferably, the blood concentration should be determined at appropriate intervals.

The use of this antibiotic, as with other antibiotics, may result in an overgrowth of nonsusceptible organisms, including fungi. If infections caused by nonsusceptible organisms appear during therapy, appropriate measures should be taken.

Laboratory Tests

Baseline blood studies should be followed by periodic blood studies approximately every two days during therapy. The drug should be discontinued upon appearance of reticulocytopenia, leukopenia, thrombocytopenia, anemia or any other blood study findings attributable to chloramphenicol. However, it should be noted that such studies do not exclude the possible later appearance of the irreversible type of bone marrow depression.

Drug Interactions

Concurrent therapy with other drugs that may cause bone marrow depression should be avoided.

Carcinogenesis, Mutagenesis, Impairment of Fertility

No studies have been conducted in animals or humans to evaluate the possibility of these effects with chloramphenicol.

Pregnancy

Pregnancy Category C - Animal reproduction studies have not been conducted with chloramphenicol. There are no adequate and well-controlled studies to establish safety of this drug in pregnancy. It is not known whether chloramphenicol can cause fetal harm when administered to a pregnant woman. Orally administered chloramphenicol has been shown to cross the placental barrier. Because of potential toxic effects on the fetus (See ADVERSE REACTIONS - “Gray Syndrome”), chloramphenicol should be given to a pregnant woman only if the potential benefit justifies the potential risk to the fetus.

Nursing Mothers

Chloramphenicol is excreted in human milk following oral administration of the drug. Because of the potential for serious adverse reactions in nursing infants from chloramphenicol, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. (See ADVERSEREACTIONS - “Gray Syndrome”).

Pediatric Use

Precaution should be used in therapy of premature and full-term neonates and infants to avoid “gray syndrome” toxicity. Due to immature metabolic processes in the neonate and infant, excessive blood levels may result from administration of the recommended dose. The dosage should be adjusted accordingly or, preferable, the blood concentration should be determined at appropriate intervals. (See ADVERSE REACTIONS - “Gray Syndrome”) See DOSAGE AND ADMINISTRATION for dosing information in the pediatric population.

Adverse Reactions

1. Blood Dyscrasias

The most serious adverse effect of chloramphenicol is bone marrow depression. Serious and fatal blood dyscrasias (aplastic anemia, hypoplastic anemia, thrombocytopenia, and granulocytopenia) are known to occur after the administration of chloramphenicol. An irreversible type of marrow depression leading to aplastic anemia with a high rate of mortality is characterized by the appearance weeks or months after therapy of bone marrow aplastic or hypoplasia. Peripherally, pancytopenia is most often observed, but in a small number of cases only one or two of the three major cell types (erythrocytes, leukocytes, platelets) may be depressed.

A reversible type of bone marrow depression, which is dose related, may occur. This type of marrow depression is characterized by vacuolization of the erythroid cells, reduction of reticulocytes and leukopenia, and responds promptly to the withdrawal of chloramphenicol. An exact determination of the risk of serious and fatal blood dyscrasias is not possible because of lack of accurate information regarding 1) the size of the population at risk, 2) the total number of drug-associated dyscrasias, and 3) the total number of non-drug associated dyscrasias. In a report to the California State Assembly by the California Medical Association and the State Department of Public Health in January 1967, the risk of fatal aplastic anemia was estimated at 1:24,200 to 1:40,500 based on two dosage levels.

There have been reports of aplastic anemia attributed to chloramphenicol which later terminated in leukemia.

Paroxysmal nocturnal hemoglobinuria has been reported.

2. Gastrointestinal Reactions

Nausea, vomiting, glossitis and stomatitis, diarrhea and enterocolitis may occur in low incidence.

3. Neurotoxic Reactions

Headache, mild depression, mental confusion, and delirium have been described in patients receiving chloramphenicol. Optic and peripheral neuritis have been reported, usually following long-term therapy. If this occurs, the drug should be promptly withdrawn.

4. Hypersensitivity Reactions

Fever, macular and vesicular rashes, angioedema, urticaria, and anaphylaxis may occur. Herxheimer’s reactions have occurred during therapy for typhoid fever.

5. "Gray Syndrome"

Toxic reactions including fatalities have occurred in the premature and neonate; the signs and symptoms associated with these reactions have been referred to as the “gray syndrome.” One case of gray syndrome has been reported in a neonate born to a mother having received chloramphenicolduring labor. One case has been reported in a 3-month-old infant. The following summarizes the clinical and laboratory studies that have been made on these patients:

a) In most cases therapy with chloramphenicol had been instituted within the first 48 hours of life.

b) Symptoms first appeared after 3 to 4 days of continued treatment with high doses of chloramphenicol.

c) The symptoms appeared in the following order:

(1) abdominal distension with or without emesis;

(2) progressive pallid cyanosis;

(3) vasomotor collapse, frequently accompanied by irregular respiration;

(4) death within a few hours of onset of these symptoms.

d) The progression of symptoms from onset to exitus was accelerated with higher dose schedules.

e) Preliminary blood serum level studies revealed unusually high concentrations of chloramphenicol (over 90 mcg/mL after repeated doses).

f) Termination of therapy upon early evidence of the associated symptomatology frequently reversed the process with complete recovery.

Dosage and Administration

Chloramphenicol, like other potent drugs, should be prescribed at recommended doses known to have therapeutic activity. Administration of 50 mg/kg/day in divided doses will produce blood levels of the magnitude to which the majority of susceptible microorganisms will respond.

As soon as feasible an oral dosage form of another appropriate antibiotic should be substituted for intravenous chloramphenicol sodium succinate.

The following method of administration is recommended:

Intravenously as a 10% (100 mg/mL) solution to be injected over at least a one-minute interval. This is prepared by the addition of 10 mL of an aqueous diluent such as water for injection or 5% dextrose injection.

Adults

Adults should receive 50 mg/kg/day in divided doses at 6-hour intervals. In exceptional cases patients with infections due to moderately resistant organisms may require increased dosage up to 100 mg/kg/day to achieve blood levels inhibiting the pathogen, but these high doses should be decreased as soon as possible. Adults with impairment of hepatic or renal function or both may have reduced ability to metabolize and excrete the drug. In instances of impaired metabolic processes, dosages should be adjusted accordingly. (See discussion under Neonates.) Precise control of concentration of the drug in the blood should be carefully followed in patients with impaired metabolic processes by the available microtechniques (information available on request).

Pediatric Patients

Dosage of 50 mg/kg/day divided into 4 doses at 6-hour intervals yields blood levels in the range effective against most susceptible organisms. Severe infections (eg, bacteremia or meningitis), especially when adequate cerebrospinal fluid concentrations are desired, may require dosage up to 100 mg/kg/day; however, it is recommended that dosage be reduced to 50 mg/kg/day as soon as possible. Children with impaired liver or kidney function may retain excessive amounts of the drug.

Neonates

(See section titled “Gray Syndrome” under ADVERSE REACTIONS.)

A total of 25 mg/kg/day in 4 equal doses at 6-hour intervals usually produces and maintains concentrations in blood and tissues adequate to control most infections for which the drug is indicated. Increased dosage in these individuals, demanded by severe infections, should be given only to maintain the blood concentration within a therapeutically effective range. After the first two weeks of life, full-term neonates ordinarily may receive up to a total of 50 mg/kg/day equally divided into 4 doses at 6-hour intervals. These dosage recommendations are extremely important because blood concentration in all premature and full-term neonates under two weeks of age differs from that of other infants neonates. This difference is due to variations in the maturity of the metabolic functions of the liver and the kidneys.

When these functions are immature (or seriously impaired in adults), high concentrations of the drug are found which tend to increase with succeeding doses.

Pediatric Patients with Immature Metabolic Processes

In young infants and other pediatric patients in whom immature metabolic functions are suspected, a dose of 25 mg/kg/day will usually produce therapeutic concentrations of the drug in the blood. In this group particularly, the concentration of the drug in the blood should be carefully followed by microtechniques. (Information available on request.)

How Supplied

NDC 61570-405-71 (Steri-Vial® No 57)

Chloromycetin Sodium Succinate is freeze-dried in the vial and supplied in Steri-Vials (rubber-diaphragm-capped vials). When reconstituted as directed, each vial contains a sterile solution equivalent to 100 mg of chloramphenicol per mL (1 g/10 mL). Available in packages of 10 vials.

Store between 15° and 25°C (59° and 77°F).

Rx only.

References

  1. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition. Approved Standard NCCLS Document M7-A4, Vol. 17, No. 2, NCCLS, Wayne, PA, January, 1997.

  2. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests - Sixth Edition. Approved Standard NCCLS Document M2-A6, Vol. 17, No. 1, NCCLS, Wayne, PA, January, 1997.

  3. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing - Eighth Informational Supplement. Approved Standard NCCLS Document M100-S8, Vol. 18, No. 1, NCCLS, Wayne, PA, January, 1998.

Revised May 1999

Manufactured by: Parkedale Pharmaceuticals, Inc., Rochester, MI 48307

Distributed by: Monarch Pharmaceuticals, Inc., Bristol, TN 37620


Chloromycetin Sodium Succinate (chloramphenicol sodium succinate)
PRODUCT INFO
Product Code 61570-405 Dosage Form INJECTION
Route Of Administration INTRAVENOUS DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
Chloramphenicol sodium succinate (chloramphenicol) Active 100 MILLIGRAM  In 1 MILLILITER
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 61570-405-71 10 VIAL In 1 PACKAGE contains a VIAL
1 10 MILLILITER In 1 VIAL This package is contained within the PACKAGE (61570-405-71)

Revised: 04/2007





Where can I get more information about Chloromycetin Chloromycetin ophthalmic ointment ? We recommend to use www.Drugs.com

Typical mistypes for Chloromycetin Chloromycetin ophthalmic ointment
xhloromycetin chloromycetin ophthalmic ointment, vhloromycetin chloromycetin ophthalmic ointment, fhloromycetin chloromycetin ophthalmic ointment, dhloromycetin chloromycetin ophthalmic ointment, cgloromycetin chloromycetin ophthalmic ointment, cbloromycetin chloromycetin ophthalmic ointment, cnloromycetin chloromycetin ophthalmic ointment, cjloromycetin chloromycetin ophthalmic ointment, culoromycetin chloromycetin ophthalmic ointment, cyloromycetin chloromycetin ophthalmic ointment, chkoromycetin chloromycetin ophthalmic ointment, chporomycetin chloromycetin ophthalmic ointment, chooromycetin chloromycetin ophthalmic ointment, chliromycetin chloromycetin ophthalmic ointment, chlkromycetin chloromycetin ophthalmic ointment, chllromycetin chloromycetin ophthalmic ointment, chlpromycetin chloromycetin ophthalmic ointment, chl0romycetin chloromycetin ophthalmic ointment, chl9romycetin chloromycetin ophthalmic ointment, chloeomycetin chloromycetin ophthalmic ointment, chlodomycetin chloromycetin ophthalmic ointment, chlofomycetin chloromycetin ophthalmic ointment, chlotomycetin chloromycetin ophthalmic ointment, chlo5omycetin chloromycetin ophthalmic ointment, chlo4omycetin chloromycetin ophthalmic ointment, chlorimycetin chloromycetin ophthalmic ointment, chlorkmycetin chloromycetin ophthalmic ointment, chlorlmycetin chloromycetin ophthalmic ointment, chlorpmycetin chloromycetin ophthalmic ointment, chlor0mycetin chloromycetin ophthalmic ointment, chlor9mycetin chloromycetin ophthalmic ointment, chloronycetin chloromycetin ophthalmic ointment, chlorokycetin chloromycetin ophthalmic ointment, chlorojycetin chloromycetin ophthalmic ointment, chloromtcetin chloromycetin ophthalmic ointment, chloromgcetin chloromycetin ophthalmic ointment, chloromhcetin chloromycetin ophthalmic ointment, chloromucetin chloromycetin ophthalmic ointment, chlorom7cetin chloromycetin ophthalmic ointment, chlorom6cetin chloromycetin ophthalmic ointment, chloromyxetin chloromycetin ophthalmic ointment, chloromyvetin chloromycetin ophthalmic ointment, chloromyfetin chloromycetin ophthalmic ointment, chloromydetin chloromycetin ophthalmic ointment, chloromycwtin chloromycetin ophthalmic ointment, chloromycstin chloromycetin ophthalmic ointment, chloromycdtin chloromycetin ophthalmic ointment, chloromycrtin chloromycetin ophthalmic ointment, chloromyc4tin chloromycetin ophthalmic ointment, chloromyc3tin chloromycetin ophthalmic ointment, chloromycerin chloromycetin ophthalmic ointment, chloromycefin chloromycetin ophthalmic ointment, chloromycegin chloromycetin ophthalmic ointment, chloromyceyin chloromycetin ophthalmic ointment, chloromyce6in chloromycetin ophthalmic ointment, chloromyce5in chloromycetin ophthalmic ointment, chloromycetun chloromycetin ophthalmic ointment, chloromycetjn chloromycetin ophthalmic ointment, chloromycetkn chloromycetin ophthalmic ointment, chloromyceton chloromycetin ophthalmic ointment, chloromycet9n chloromycetin ophthalmic ointment, chloromycet8n chloromycetin ophthalmic ointment, chloromycetib chloromycetin ophthalmic ointment, chloromycetim chloromycetin ophthalmic ointment, chloromycetij chloromycetin ophthalmic ointment, chloromycetih chloromycetin ophthalmic ointment, chloromycetin xhloromycetin ophthalmic ointment, chloromycetin vhloromycetin ophthalmic ointment, chloromycetin fhloromycetin ophthalmic ointment, chloromycetin dhloromycetin ophthalmic ointment, chloromycetin cgloromycetin ophthalmic ointment, chloromycetin cbloromycetin ophthalmic ointment, chloromycetin cnloromycetin ophthalmic ointment, chloromycetin cjloromycetin ophthalmic ointment, chloromycetin culoromycetin ophthalmic ointment, chloromycetin cyloromycetin ophthalmic ointment, chloromycetin chkoromycetin ophthalmic ointment, chloromycetin chporomycetin ophthalmic ointment, chloromycetin chooromycetin ophthalmic ointment, chloromycetin chliromycetin ophthalmic ointment, chloromycetin chlkromycetin ophthalmic ointment, chloromycetin chllromycetin ophthalmic ointment, chloromycetin chlpromycetin ophthalmic ointment, chloromycetin chl0romycetin ophthalmic ointment, chloromycetin chl9romycetin ophthalmic ointment, chloromycetin chloeomycetin ophthalmic ointment, chloromycetin chlodomycetin ophthalmic ointment, chloromycetin chlofomycetin ophthalmic ointment, chloromycetin chlotomycetin ophthalmic ointment, chloromycetin chlo5omycetin ophthalmic ointment, chloromycetin chlo4omycetin ophthalmic ointment, chloromycetin chlorimycetin ophthalmic ointment, chloromycetin chlorkmycetin ophthalmic ointment, chloromycetin chlorlmycetin ophthalmic ointment, chloromycetin chlorpmycetin ophthalmic ointment, chloromycetin chlor0mycetin ophthalmic ointment, chloromycetin chlor9mycetin ophthalmic ointment, chloromycetin chloronycetin ophthalmic ointment, chloromycetin chlorokycetin ophthalmic ointment, chloromycetin chlorojycetin ophthalmic ointment, chloromycetin chloromtcetin ophthalmic ointment, chloromycetin chloromgcetin ophthalmic ointment, chloromycetin chloromhcetin ophthalmic ointment, chloromycetin chloromucetin ophthalmic ointment, chloromycetin chlorom7cetin ophthalmic ointment, chloromycetin chlorom6cetin ophthalmic ointment, chloromycetin chloromyxetin ophthalmic ointment, chloromycetin chloromyvetin ophthalmic ointment, chloromycetin chloromyfetin ophthalmic ointment, chloromycetin chloromydetin ophthalmic ointment, chloromycetin chloromycwtin ophthalmic ointment, chloromycetin chloromycstin ophthalmic ointment, chloromycetin chloromycdtin ophthalmic ointment, chloromycetin chloromycrtin ophthalmic ointment, chloromycetin chloromyc4tin ophthalmic ointment, chloromycetin chloromyc3tin ophthalmic ointment, chloromycetin chloromycerin ophthalmic ointment, chloromycetin chloromycefin ophthalmic ointment, chloromycetin chloromycegin ophthalmic ointment, chloromycetin chloromyceyin ophthalmic ointment, chloromycetin chloromyce6in ophthalmic ointment, chloromycetin chloromyce5in ophthalmic ointment, chloromycetin chloromycetun ophthalmic ointment, chloromycetin chloromycetjn ophthalmic ointment, chloromycetin chloromycetkn ophthalmic ointment, chloromycetin chloromyceton ophthalmic ointment, chloromycetin chloromycet9n ophthalmic ointment, chloromycetin chloromycet8n ophthalmic ointment, chloromycetin chloromycetib ophthalmic ointment, chloromycetin chloromycetim ophthalmic ointment, chloromycetin chloromycetij ophthalmic ointment, chloromycetin chloromycetih ophthalmic ointment, chloromycetin chloromycetin iphthalmic ointment, chloromycetin chloromycetin kphthalmic ointment, chloromycetin chloromycetin lphthalmic ointment, chloromycetin chloromycetin pphthalmic ointment, chloromycetin chloromycetin 0phthalmic ointment, chloromycetin chloromycetin 9phthalmic ointment, chloromycetin chloromycetin oohthalmic ointment, chloromycetin chloromycetin olhthalmic ointment, chloromycetin chloromycetin o-hthalmic ointment, chloromycetin chloromycetin o0hthalmic ointment, chloromycetin chloromycetin opgthalmic ointment, chloromycetin chloromycetin opbthalmic ointment, chloromycetin chloromycetin opnthalmic ointment, chloromycetin chloromycetin opjthalmic ointment, chloromycetin chloromycetin oputhalmic ointment, chloromycetin chloromycetin opythalmic ointment, chloromycetin chloromycetin ophrhalmic ointment, chloromycetin chloromycetin ophfhalmic ointment, chloromycetin chloromycetin ophghalmic ointment, chloromycetin chloromycetin ophyhalmic ointment, chloromycetin chloromycetin oph6halmic ointment, chloromycetin chloromycetin oph5halmic ointment, chloromycetin chloromycetin ophtgalmic ointment, chloromycetin chloromycetin ophtbalmic ointment, chloromycetin chloromycetin ophtnalmic ointment, chloromycetin chloromycetin ophtjalmic ointment, chloromycetin chloromycetin ophtualmic ointment, chloromycetin chloromycetin ophtyalmic ointment, chloromycetin chloromycetin ophthzlmic ointment, chloromycetin chloromycetin ophthslmic ointment, chloromycetin chloromycetin ophthwlmic ointment, chloromycetin chloromycetin ophthqlmic ointment, chloromycetin chloromycetin ophthakmic ointment, chloromycetin chloromycetin ophthapmic ointment, chloromycetin chloromycetin ophthaomic ointment, chloromycetin chloromycetin ophthalnic ointment, chloromycetin chloromycetin ophthalkic ointment, chloromycetin chloromycetin ophthaljic ointment, chloromycetin chloromycetin ophthalmuc ointment, chloromycetin chloromycetin ophthalmjc ointment, chloromycetin chloromycetin ophthalmkc ointment, chloromycetin chloromycetin ophthalmoc ointment, chloromycetin chloromycetin ophthalm9c ointment, chloromycetin chloromycetin ophthalm8c ointment, chloromycetin chloromycetin ophthalmix ointment, chloromycetin chloromycetin ophthalmiv ointment, chloromycetin chloromycetin ophthalmif ointment, chloromycetin chloromycetin ophthalmid ointment, chloromycetin chloromycetin ophthalmic iintment, chloromycetin chloromycetin ophthalmic kintment, chloromycetin chloromycetin ophthalmic lintment, chloromycetin chloromycetin ophthalmic pintment, chloromycetin chloromycetin ophthalmic 0intment, chloromycetin chloromycetin ophthalmic 9intment, chloromycetin chloromycetin ophthalmic ountment, chloromycetin chloromycetin ophthalmic ojntment, chloromycetin chloromycetin ophthalmic okntment, chloromycetin chloromycetin ophthalmic oontment, chloromycetin chloromycetin ophthalmic o9ntment, chloromycetin chloromycetin ophthalmic o8ntment, chloromycetin chloromycetin ophthalmic oibtment, chloromycetin chloromycetin ophthalmic oimtment, chloromycetin chloromycetin ophthalmic oijtment, chloromycetin chloromycetin ophthalmic oihtment, chloromycetin chloromycetin ophthalmic oinrment, chloromycetin chloromycetin ophthalmic oinfment, chloromycetin chloromycetin ophthalmic oingment, chloromycetin chloromycetin ophthalmic oinyment, chloromycetin chloromycetin ophthalmic oin6ment, chloromycetin chloromycetin ophthalmic oin5ment, chloromycetin chloromycetin ophthalmic ointnent, chloromycetin chloromycetin ophthalmic ointkent, chloromycetin chloromycetin ophthalmic ointjent, chloromycetin chloromycetin ophthalmic ointmwnt, chloromycetin chloromycetin ophthalmic ointmsnt, chloromycetin chloromycetin ophthalmic ointmdnt, chloromycetin chloromycetin ophthalmic ointmrnt, chloromycetin chloromycetin ophthalmic ointm4nt, chloromycetin chloromycetin ophthalmic ointm3nt, chloromycetin chloromycetin ophthalmic ointmebt, chloromycetin chloromycetin ophthalmic ointmemt, chloromycetin chloromycetin ophthalmic ointmejt, chloromycetin chloromycetin ophthalmic ointmeht, chloromycetin chloromycetin ophthalmic ointmenr, chloromycetin chloromycetin ophthalmic ointmenf, chloromycetin chloromycetin ophthalmic ointmeng, chloromycetin chloromycetin ophthalmic ointmeny, chloromycetin chloromycetin ophthalmic ointmen6, chloromycetin chloromycetin ophthalmic ointmen5, hloromycetin chloromycetin ophthalmic ointment, cloromycetin chloromycetin ophthalmic ointment, choromycetin chloromycetin ophthalmic ointment, chlromycetin chloromycetin ophthalmic ointment, chloomycetin chloromycetin ophthalmic ointment, chlormycetin chloromycetin ophthalmic ointment, chloroycetin chloromycetin ophthalmic ointment, chloromcetin chloromycetin ophthalmic ointment, chloromyetin chloromycetin ophthalmic ointment, chloromyctin chloromycetin ophthalmic ointment, chloromycein chloromycetin ophthalmic ointment, chloromycetn chloromycetin ophthalmic ointment, chloromyceti chloromycetin ophthalmic ointment, chloromycetin chloromycetin ophthalmic ointment, chloromycetin chloromycetin ophthalmic ointment, chloromycetin hloromycetin ophthalmic ointment, chloromycetin cloromycetin ophthalmic ointment, chloromycetin choromycetin ophthalmic ointment, chloromycetin chlromycetin ophthalmic ointment, chloromycetin chloomycetin ophthalmic ointment, chloromycetin chlormycetin ophthalmic ointment, chloromycetin chloroycetin ophthalmic ointment, chloromycetin chloromcetin ophthalmic ointment, chloromycetin chloromyetin ophthalmic ointment, chloromycetin chloromyctin ophthalmic ointment, chloromycetin chloromycein ophthalmic ointment, chloromycetin chloromycetn ophthalmic ointment, chloromycetin chloromyceti ophthalmic ointment, chloromycetin chloromycetinophthalmic ointment, chloromycetin chloromycetin phthalmic ointment, chloromycetin chloromycetin ohthalmic ointment, chloromycetin chloromycetin opthalmic ointment, chloromycetin chloromycetin ophhalmic ointment, chloromycetin chloromycetin ophtalmic ointment, chloromycetin chloromycetin ophthlmic ointment, chloromycetin chloromycetin ophthamic ointment, chloromycetin chloromycetin ophthalic ointment, chloromycetin chloromycetin ophthalmc ointment, chloromycetin chloromycetin ophthalmi ointment, chloromycetin chloromycetin ophthalmicointment, chloromycetin chloromycetin ophthalmic intment, chloromycetin chloromycetin ophthalmic ontment, chloromycetin chloromycetin ophthalmic oitment, chloromycetin chloromycetin ophthalmic oinment, chloromycetin chloromycetin ophthalmic ointent, chloromycetin chloromycetin ophthalmic ointmnt, chloromycetin chloromycetin ophthalmic ointmet, chloromycetin chloromycetin ophthalmic ointmen, hcloromycetin chloromycetin ophthalmic ointment, clhoromycetin chloromycetin ophthalmic ointment, cholromycetin chloromycetin ophthalmic ointment, chlroomycetin chloromycetin ophthalmic ointment, chloormycetin chloromycetin ophthalmic ointment, chlormoycetin chloromycetin ophthalmic ointment, chloroymcetin chloromycetin ophthalmic ointment, chloromcyetin chloromycetin ophthalmic ointment, chloromyectin chloromycetin ophthalmic ointment, chloromyctein chloromycetin ophthalmic ointment, chloromyceitn chloromycetin ophthalmic ointment, chloromycetni chloromycetin ophthalmic ointment, chloromyceti n chloromycetin ophthalmic ointment, chloromycetin chloromycetin ophthalmic ointment, chloromycetin c hloromycetin ophthalmic ointment, chloromycetin hcloromycetin ophthalmic ointment, chloromycetin clhoromycetin ophthalmic ointment, chloromycetin cholromycetin ophthalmic ointment, chloromycetin chlroomycetin ophthalmic ointment, chloromycetin chloormycetin ophthalmic ointment, chloromycetin chlormoycetin ophthalmic ointment, chloromycetin chloroymcetin ophthalmic ointment, chloromycetin chloromcyetin ophthalmic ointment, chloromycetin chloromyectin ophthalmic ointment, chloromycetin chloromyctein ophthalmic ointment, chloromycetin chloromyceitn ophthalmic ointment, chloromycetin chloromycetni ophthalmic ointment, chloromycetin chloromyceti nophthalmic ointment, chloromycetin chloromycetino phthalmic ointment, chloromycetin chloromycetin pohthalmic ointment, chloromycetin chloromycetin ohpthalmic ointment, chloromycetin chloromycetin opthhalmic ointment, chloromycetin chloromycetin ophhtalmic ointment, chloromycetin chloromycetin ophtahlmic ointment, chloromycetin chloromycetin ophthlamic ointment, chloromycetin chloromycetin ophthamlic ointment, chloromycetin chloromycetin ophthalimc ointment, chloromycetin chloromycetin ophthalmci ointment, chloromycetin chloromycetin ophthalmi cointment, chloromycetin chloromycetin ophthalmico intment, chloromycetin chloromycetin ophthalmic iontment, chloromycetin chloromycetin ophthalmic onitment, chloromycetin chloromycetin ophthalmic oitnment, chloromycetin chloromycetin ophthalmic oinmtent, chloromycetin chloromycetin ophthalmic ointemnt, chloromycetin chloromycetin ophthalmic ointmnet, chloromycetin chloromycetin ophthalmic ointmetn, cchloromycetin chloromycetin ophthalmic ointment, chhloromycetin chloromycetin ophthalmic ointment, chlloromycetin chloromycetin ophthalmic ointment, chlooromycetin chloromycetin ophthalmic ointment, chlorromycetin chloromycetin ophthalmic ointment, chloroomycetin chloromycetin ophthalmic ointment, chlorommycetin chloromycetin ophthalmic ointment, chloromyycetin chloromycetin ophthalmic ointment, chloromyccetin chloromycetin ophthalmic ointment, chloromyceetin chloromycetin ophthalmic ointment, chloromycettin chloromycetin ophthalmic ointment, chloromycetiin chloromycetin ophthalmic ointment, chloromycetinn chloromycetin ophthalmic ointment, chloromycetin chloromycetin ophthalmic ointment, chloromycetin chloromycetin ophthalmic ointment, chloromycetin cchloromycetin ophthalmic ointment, chloromycetin chhloromycetin ophthalmic ointment, chloromycetin chlloromycetin ophthalmic ointment, chloromycetin chlooromycetin ophthalmic ointment, chloromycetin chlorromycetin ophthalmic ointment, chloromycetin chloroomycetin ophthalmic ointment, chloromycetin chlorommycetin ophthalmic ointment, chloromycetin chloromyycetin ophthalmic ointment, chloromycetin chloromyccetin ophthalmic ointment, chloromycetin chloromyceetin ophthalmic ointment, chloromycetin chloromycettin ophthalmic ointment, chloromycetin chloromycetiin ophthalmic ointment, chloromycetin chloromycetinn ophthalmic ointment, chloromycetin chloromycetin ophthalmic ointment, chloromycetin chloromycetin oophthalmic ointment, chloromycetin chloromycetin opphthalmic ointment, chloromycetin chloromycetin ophhthalmic ointment, chloromycetin chloromycetin ophtthalmic ointment, chloromycetin chloromycetin ophthhalmic ointment, chloromycetin chloromycetin ophthaalmic ointment, chloromycetin chloromycetin ophthallmic ointment, chloromycetin chloromycetin ophthalmmic ointment, chloromycetin chloromycetin ophthalmiic ointment, chloromycetin chloromycetin ophthalmicc ointment, chloromycetin chloromycetin ophthalmic ointment, chloromycetin chloromycetin ophthalmic oointment, chloromycetin chloromycetin ophthalmic oiintment, chloromycetin chloromycetin ophthalmic oinntment, chloromycetin chloromycetin ophthalmic ointtment, chloromycetin chloromycetin ophthalmic ointmment, chloromycetin chloromycetin ophthalmic ointmeent, chloromycetin chloromycetin ophthalmic ointmennt, chloromycetin chloromycetin ophthalmic ointmentt, etc.



© Copyright by drug-information.ru 2001-2019. All rights reserved